SMAD3 and hepatocellular carcinoma: A recent study had demonstrated that SMAD3 could promote migration, invasion, and metastasis of HCC cells in vitro and in vivo, binding directly to PTPRε promoters to activate its expression, and then feedback to activate TGF-β1/SMAD3 signaling to promote HCC metastasis [40].